EPIC-NL
European Prospective Investigation Into Cancer and Nutrition in the Netherlands (EPIC-NL)...
Description
EPIC is the European Prospective Investigation Into Cancer and Nutrition. EPIC-NL is the Dutch contribution to EPIC and comprises about 40,000 individuals prospectively followed since the early 90's. Biological samples have been stored in liquid nitr...
General Design
- Cohort type
Population cohort
- Design
Longitudinal
- Design description
At baseline, the prevalence of risk factors for chronic diseases was determined using self-administered questionnaires and a physical examination. Participants are followed up over time for changes in exposure and for the occurrence of cancer, diabetes, cardiovascular diseases, and other medical conditions.
- Collection type
Prospective
- Start/End year
1993 - ongoing
- Design paper
- Cohort Profile: The EPIC-NL study
Population
- Countries
Netherlands (the)
- Regions
Limburg, Noord-Holland, Utrecht, Gelderland
- Number of participants
40010
- Number of participants with samples
40010
- Population age groups
Adult (18+ years)
- Inclusion criteria
- Age group inclusion criterion
Contributors
Lead organisation
- UMC Utrecht
- Rijksinstituut voor Volksgezondheid en Milieu
Contributors
- Monique Verschurenmonique.verschuren@rivm.nl
- Roel Vermeulenrvermeu3@umcutrecht.nl
Available Data & Samples
Data categories
- Survey data
- Biological samples
- Physiological/Biochemical measurements
- National registries
Sample categories
- Serum
- Blood
- Blood (whole)
- Blood Buffy Coat
- Plasma
Areas of information
- Lifestyle and behaviours
- Tobacco
- Alcohol
- Physical activity
- Sleep
- Nutrition
- Breastfeeding
- Transportation
- Birth, pregnancy and reproductive health history
- Puberty, menstruation, menopause and andropause
- Contraception
- Fertility and sexual health
- Pregnancy, delivery and birth
- Other reproductive health-related information
- Perception of health, quality of life, development and functional limitations
- Other perception of health, quality of life and functional limitation-related information
- Perception of health
- Symptoms and signs
- Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
- Symptoms and signs involving the skin and subcutaneous tissue (R20-R23)
- Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
- Symptoms and signs involving the digestive system and abdomen (R10-R19)
- Symptoms and signs involving nervous and musculoskeletal systems (R25-R29)
- General symptoms and signs (R50-R69)
- Medication and supplements
- Medication and supplement intake
- Physical measures and assessments
- Anthropometry
- Circulation and respiration
- Sensory and pain
- Cognition, personality and psychological measures and assessments
- Psychological distress and emotions
- Physical environment
- Housing characteristics
- Workplace characteristics
- Radiation exposure
- Chemical exposure
- Socio-demographic and economic characteristics
- Age/birthdate
- Sex/gender
- Marital/partner status
- Education
- Residence
- Birthplace
- Labour force and retirement
- Laboratory measures
- Hematology
- Health and community care services utilization
- Visits to health professionals
- Hospitalizations
Subpopulations
List of subcohorts or subpopulations for this resource...
| Name | Description | Number of participants |
|---|
Collection events
List of collection events defined for this resource...
| Name | Description | Participants | Start end year |
|---|
Networks
List of networks in which this cohort is involved...
Access conditions
a data request is judged by the scientific steering committee...
- Data access conditions
- health or medical or biomedical research
- disease specific research
- Data use conditions
- research specific restrictions
- not for profit, non commercial use only
- Release type
- Other release type
- Release description
at request
- Prelinked
true
- Linkage options
CBS (national bureau of statistics); IKNL-NKR (Cancer registration); GBA (municipal registry for current address and vital status)
Funding & Acknowledgements
- Funding
The EPIC-NL study was funded by ‘Europe against Cancer’ Programme of the European Commission (SANCO); the Dutch Ministry of Public Health, Welfare and Sports (formerly Ministry of Welfare, Public Health and Culture); the Dutch Cancer Society; ZonMW the Netherlands Organisation for Health Research and Development; and World Cancer Research Fund (WCRF).
- Acknowledgements
We thank GBA, Statistics Netherlands, Dutch Cancer Registry and the institute PHARMO for providing data on vital status, cause of death and occurrence of cancer and other chronic diseases.